Concepedia

Author

Montserrat Puntes

Universitat Autònoma de Barcelona

Also Known As

Montserrat Puntes

12

Publications

203

Citations

7

H-Index

5

Concepts

All Affiliations

Universitat Autònoma de BarcelonaHospital de Sant PauCentro de Investigación Biomédica en Red de Salud MentalVA Connecticut Healthcare SystemBehavioral Pharma (United States)
MP

About

Montserrat Puntes is an author at Universitat Autònoma de Barcelona specializing in pharmacokinetics, pharmacotherapy, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

10

2

Pharmacology

1

1

10

3

Drug Allergy

1

1

10

4

Pharmacokinetics

1

1

10

5

Pharmacotherapy

1

1

10

Montserrat Puntes

×

6

Publications

176

Citations

6

H-Index

YearCitations

Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans

Ana Maqueda, Marta Valle, Peter H. Addy,

The International Journal of Neuropsychopharmacology

2015

72

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans

Ana Maqueda, Marta Valle, Peter H. Addy,

The International Journal of Neuropsychopharmacology

2016

31

Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers

Rosa Antonijoan, Jimena Coimbra, Consuelo García‐Gea,

Current Medical Research and Opinion

2016

26

<i>Lactiplantibacillus plantarum</i> strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans

Teresa Padró, Victoria de Santisteban Villaplana, Pol Huedo,

Cardiovascular Research

2024

21

The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A

Genís Oña, Frederic Sampedro, Sergio Romero,

The International Journal of Neuropsychopharmacology

2021

16

Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): A randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults

Rosa Antonijoan, Consuelo García‐Gea, Montserrat Puntes,

Clinical Therapeutics

2007

10

Page 1